NM_000126.4:c.495_496delGT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000126.4(ETFA):c.495_496delGT(p.Ser167CysfsTer7) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,466 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000126.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETFA | NM_000126.4 | c.495_496delGT | p.Ser167CysfsTer7 | frameshift_variant | Exon 6 of 12 | ENST00000557943.6 | NP_000117.1 | |
ETFA | NM_001127716.2 | c.348_349delGT | p.Ser118CysfsTer7 | frameshift_variant | Exon 5 of 11 | NP_001121188.1 | ||
ETFA | XR_007064434.1 | n.576_577delGT | non_coding_transcript_exon_variant | Exon 6 of 12 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251322Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135816
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461466Hom.: 0 AF XY: 0.0000124 AC XY: 9AN XY: 727052
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple acyl-CoA dehydrogenase deficiency Pathogenic:3
Variant summary: ETFA c.495_496delGT (p.Ser167CysfsX7) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.2e-05 in 251322 control chromosomes. To our knowledge, no occurrence of c.495_496delGT in individuals affected with Glutaric Aciduria, Type 2a and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change creates a premature translational stop signal (p.Ser167Cysfs*7) in the ETFA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ETFA are known to be pathogenic (PMID: 16510302, 23785301). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ETFA-related conditions. ClinVar contains an entry for this variant (Variation ID: 459956). For these reasons, this variant has been classified as Pathogenic. -
ETFA-related disorder Pathogenic:1
The ETFA c.495_496delGT variant is predicted to result in a frameshift and premature protein termination (p.Ser167Cysfs*7). To our knowledge, this variant has not been reported in the literature. It has been reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-76578777-AAC-A). Frameshift variants in ETFA are expected to be pathogenic, and therefore this variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at